Access Program for ABBV-706 Before Official Approval

Sponsor: AbbVie

Expanded Access
Sponsor score: 60

ClinicalTrials ID:NCT07310277

Provider View

This program allows eligible patients to access the investigational drug ABBV-706 before it is officially approved by health authorities. A doctor will determine if the potential benefits of the drug outweigh the risks for each patient.

Patient Parameters

Program Overview

This program is designed to provide patients with access to ABBV-706, a drug that is not yet approved by local health authorities. The availability of this drug will depend on the rules in different areas. A doctor will evaluate each patient's medical history to decide if the benefits of taking this investigational drug are greater than the risks. Patients must meet certain criteria to be eligible for this program.

Eligibility Criteria

Exclusion Criteria

  • Other suitable treatment options are available.
  • The participant is eligible for ongoing clinical trials.

Get This Program In Your Inbox

Receive detailed information about this treatment opportunity to review with your healthcare provider.